DCGI seeks more data from SII over its application seeking emergency authorisation for Covovax

Serum Institute of India (SII) had sent an application to the DCGI in October for the grant of market authorisation of Covovax for restricted use in emergency situations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3svo5DU
via IFTTT